Pfizer Satellite Symposium
Friday April 23rd, 2010
09.00-10.45 Room C
(not CME accredited)
Cancer-Associated Thrombosis: can we meet the challenge?
Chairman: A.K. Kakkar (UK)
09.00 Opening - A.K. Kakkar
09.05 Cancer-Associated Thrombosis: Is it always relevant? - H.A. Liebman (USA)
09.20 Can we reliably predict who is at Risk? - C. Francis (USA)
09.35 Treating VTE in Cancer - A.K. Kakkar
09.50 Interactive case study session
Case Study 1: Central Venous Catheters - B. Brenner (Israel)
09.58 Case Study 2: Prophylaxis of a Cancer Patient undergoing Surgery - C. Francis
10.06 Case Study 3: Asymptomatic VTE found during staging - H.A. Liebman
10.14 Case Study 4: Treatment of Cancer-Associated Thrombosis - A.K. Kakkar
10.22 Case Study 5: Haematological Cancer Patient - B. Brenner
10.30 Q&A
10.40 Closing Remarks - A.K. Kakkar
LEO Pharma Satellite Symposium
Friday April 23rd, 2010
09.30-12.45 Auditorium
(not CME accredited)
Beating Blood Clots
Challenges in the treatment and prevention of venous thromboembolism in cancer patients: an interactive session
Chairs: A. Lee (Canada), R. Bauersachs (Germany)
09.30 Welcome and introduction by chairs - A. Lee, R. Bauersachs
09.40 Diagnosis and treatment of VTE in cancer-difficult clinical decisions - P. Kamphuisen (The Netherlands)
10.10 Management of cancer patients with VTE: what to do when evidence is lacking? - S. Noble (UK)
10.40 Coffee break
11.00 VTE guidelines: the oncologist's view - A.A. Khorana (USA)
11.30 Introduction to interactive session - A. Lee, R. Bauersachs
11.35 Case 1 - R. Bauersachs
12.05 Case 2 - G. Meyer (France)
12.35 - 12.45 Summary - A. Lee, R. Bauersachs
GSK Satellite Symposium
Friday April 23rd, 2010
11.30-13.00 Room C
(not CME accredited)
New Developments in LMWH Benefits for Cancer Patients
Chairmen: H. Buller (Netherlands) and A. Falanga (Italy)
11.30 Introduction - H. Buller
11.45 VTE Prevention following Cancer Surgery - W. Ageno (Italy)
12.00 VTE Prevention during Chemotherapy - G. Agnelli (Italy)
12.15 VTE Treatment in Cancer Patients - A.T. Cohen (UK)
12.30 ESMO Guidelines: VTE Management with LMWH in Cancer Patients - A. Falanga
12.45 Q&A session
Sanofi Aventis Lunch Session
Saturday April 24th, 2010
13.00-14.00 Room C
(not CME accredited)
VTE in Oncology - From Guidelines to Clinical Practice
Chairmen: B. Brenner (Israel), W. Ageno (Italy)
13.00 Introduction
13.05 VTE Risk in Oncology: Suggestions and Open Issues in Guidelines - G. Palareti (Italy)
13.25 VTE Treatment in Cancer - D. Imberti (Italy)
13.45 Discussion
